CHONGQING, China, April 22, 2025 /PRNewswire/ — A news report from iChongqing – On April 21, the Stories of the CPC: Achievements of Chongqing in Practicing Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era thematic briefing took place in Chongqing.
Over 200 participants, including political leaders from more than 50 countries, foreign diplomats in China, and international business representatives, attended the event.
The event explored Chongqing’s role in Chinese-style modernization, addressing the question of what it truly looks like through featured activities like an Economic and Trade Promotion Meeting, Themed Dialogue Session, and a field visit to Minzhucun community.
Foreign guests experienced Chongqing’s night views. (Photo/Visual Chongqing)
At the thematic briefing, six CPC members living and working in Chongqing shared their stories of dedication, shedding light on the city’s achievements in fields such as intelligent manufacturing, opening-up, urban governance, rural revitalization, and urban renewal.
One key theme was the ongoing journey of openness, shared by Lyu Sixiang, a train driver from China Railway Chengdu Group’s Chongqing Locomotive Depot.
Anna Cordi from Germany was impressed that workers like train drivers and city staff could share their stories at a major event. She said the China Railway Express has reshaped global trade by connecting China and Europe.
Julian Mordarski, Editor-in-Chief of Poland’s Dziennik Trybuna, noted that the event deepened his understanding of smart cities. “Chongqing shows how a smart city really works,” he said, adding that while Poland lacks similar technology, he sees future possibilities for collaboration with Chinese experts to build a smart city in Poland.
In addition to the story sharing, the event featured expert views, including John Ross, Director of Economic and Business Policy for London’s Mayor and Senior Fellow at Chongyang Institute for Financial Studies at Renmin University of China.
Ross compared Chongqing with London, pointing out the differences in transportation systems and education. “While London and New York are major financial hubs, Chongqing is a global manufacturing powerhouse,” he said.
John also highlighted the need for Chongqing, like other major cities, to continue expanding internationally. He suggested that to effectively market a city, the promotion should be centered around its core strengths, with more localized efforts to build upon Chongqing’s unique position.
FORNEBU, Norway, April 22, 2025 /PRNewswire/ — Mainstream Renewable Power (“Mainstream”), the pureplay global wind and solar company majority-owned by Aker Horizons ASA, announced that it has sold its 675 MW portfolio of wind and solar assets under development in Colombia to Celsia, a local energy company, part of the Argos Group. The divestment marks Mainstream’s exit from the Colombian market.
The assets, which Mainstream has been developing since 2019, comprise three solar projects and two wind projects; the 100 MW Andromeda solar farm, the 175 MW Aries solar farm, the 100 MW Pollux solar farm as well as the 150 MW Neptuno and 150 MW Sirius wind farms.
The transaction aligns with the company’s updated and more focused strategy, concentrating on developing its pipeline of projects primarily in three core markets where it sees the greatest potential for value creation – South Africa, Australia, and the Philippines – and creating value through strong project execution, a lean cost base and capital efficiency, including capital recycling.
For further information, please contact: Jonas Gamre, Investor Relations, tel: +47 97 11 82 92, email: jonas.gamre@akerhorizons.com
Aker Horizons develops green energy and green industry to accelerate the transition to Net Zero. The company is active in renewable energy, carbon capture and sustainable industrial assets. As part of the Aker group, Aker Horizons applies industrial, technological and capital markets expertise with a planet-positive purpose to drive decarbonization globally. Aker Horizons is listed on the Oslo Stock Exchange and headquartered in Fornebu, Norway. Across its portfolio, the company is present on five continents. www.akerhorizons.com
About Mainstream Renewable Power
Mainstream Renewable Power is a leading pure-play renewable energy company with wind and solar assets across Europe, Latin America, Africa, and Asia-Pacific. Mainstream is one of the most successful developers of gigawatt-scale renewables platforms, across onshore wind, offshore wind, and solar power generation. The company has successfully delivered 6.6 GW of wind and solar generation assets to financial close-ready and has a global project portfolio of 22.7 GW. www.mainstreamrp.com
GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ — “We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 6.2% while the order intake rose by 2.9% organically.
The performance in the quarter was mainly driven by Acute Care Therapies, where Getinge as a leading supplier is working intensively to meet higher customer demand for ventilators and consumables in ECLS.
“We also see that the positive trend for Sterile Transfer in Life Science is continuing, while the product category Bio-Processing remains challenged. Infection Control is continuing to strengthen the Surgical Workflows business area, meanwhile sales of operating tables declined compared with last year’s strong Q1,” says Mattias Perjos, President & CEO at Getinge.
Paragonix Technologies, Inc, acquired in the autumn of 2024, is continuing the growth journey and recently launched KidneyVault, which has received positive feedback from users.
“Additionally, five of the company’s six products now have EU MDR approval, representing a milestone in the ongoing expansion outside the US,” Perjos explains. “Within Life Science we launched the DPTE®-FLEX Alpha port, which minimizes the risk of contamination of sensitive biopharmaceutical medicines.
Getinge’s intention to phase out the Surgical Perfusion business is progressing according to plan.
“This will certainly impact the organic order intake and sales negatively but is expected to make a positive contribution to the adjusted operating margin as early as this year, for example, by reallocating resources to more profitable areas such as ECLS and Transplant Care, which is the product area that includes the aforementioned Paragonix.”
The recent escalation of trade barriers and geopolitical tensions ultimately affects hospitals and patients the most, since tariffs distort competition and lead to higher costs. Getinge is preparing for various scenarios and potential necessary actions, where price adjustments are one of many tools available to counteract negative effects on profitability.
“Looking at the global increasing care needs in the long term, and our leading position in key niches as well as a diverse supply chain, we are well positioned to manage the current challenges. We remain positive in our outlook for 2025 where we will continue to create value for our customers, clinical staff, and patients around the world,” says Perjos.
January-March 2025 in brief
Net sales increased organically by 6.2% (0.0) and the order intake rose by 2.9% organically (2.5).
Adjusted gross profit amounted to SEK 4,337 M (3,855) and the margin was 52.1% (51.3).
Adjusted EBITA amounted to SEK 1,003 M (842) and the margin was 12.1% (11.2).
Adjusted earnings per share amounted to SEK 2.18 (1.92).
Free cash flow amounted to SEK 160 M (944).
Phone Conference
A conference call will be held on April 22, at 13.00-14.00 p.m. CEST hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.
To participate via teleconference, please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
During the conference call a presentation will be held. To access the presentation through webcast, please use this link. A recorded version can be accessed here for 3 years.
Contact information: David Kördel, Head of Investor Relations Phone: +46 (0)10 335 0077 Email: david.kordel@getinge.com
This information is such that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on April 22, 2025, at 12.00 CEST.
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.
BEIJING, April 22, 2025 /PRNewswire/ — Cheche Group Inc. (NASDAQ: CCG) (“Cheche” or the “Company”), China’s leading auto insurance technology platform, today announced that it has entered into a partnership with Wuhu Jetour Automobile Sales Company Limited (“Jetour Auto”), an automotive brand under Chery Holding Group Co., Ltd. (“Chery Holding Group”). This collaboration marks another step forward in Cheche’s ongoing efforts to deepen its partnerships with automobile manufacturers across China.
Jetour Auto was launched by Chery Holding Group in January 2018 to meet consumer demands and master market trends. Jetour Auto evolved into an independent entity in 2021 operating with its own research and development, procurement and marketing departments. Chery Holding Group ranks among China’s top ten automobile manufacturers by sales volume, with over 2.5 million vehicles sold in 2024 and making its debut on the Fortune Global 500 list the same year.
To better serve its customers, Jetour Auto has turned to Cheche’s online insurance solutions for its auto insurance application and issuance services. The Company executed a partnership agreement with Jetour Auto to provide a comprehensive digital insurance transaction platform that is currently in preparation for launch.
“We are excited to announce this new partnership with Chery Holding Group, marking a significant milestone in our journey to innovate within the automotive insurance ecosystem,” said Lei Zhang, Founder, CEO, and Chairman of Cheche. “Our industry-leading technology and comprehensive suite of digital insurance solutions will deliver a more seamless, convenient, and personalized experience for Jetour Auto’s customers. And this collaboration is just the beginning—we see tremendous potential in expanding our services and product offerings to other automotive brands within Chery Holding Group in the near future.”
Safe Harbor Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements also include, but are not limited to, statements regarding existing and new partnerships and customer relationships, projections, estimation, and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, the Company’s advantages and expected growth, and its ability to source and retain talent, as applicable. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management and are not predictions of actual performance. These statements involve risks, uncertainties, and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to materially differ from those expressed or implied by these forward-looking statements. Further information regarding these and other risks, uncertainties, or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. Although the Company believes that it has a reasonable basis for each forward-looking statement contained in this press release, the Company cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. The forward-looking statements in this press release represent the views of the Company as of the date of this press release. Subsequent events and developments may cause those views to change. Except as may be required by law, the Company does not undertake any duty to update these forward-looking statements.
About Cheche Group Inc.
Established in 2014 and headquartered in Beijing, China, Cheche is a leading auto insurance technology platform with a nationwide network of around 108 branches licensed to distribute insurance policies across 25 provinces, autonomous regions, and municipalities in China. Capitalizing on its leading position in auto insurance transaction services, Cheche has evolved into a comprehensive, data-driven technology platform that offers a full suite of services and products for digital insurance transactions and insurance SaaS solutions in China. Learn more at https://www.chechegroup.com/en.
TOKYO, April 22, 2025 /PRNewswire/ — TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF) (“TOYO” or the “Company”), a solar solution company, has officially started production at its new facility in Ethiopia in early April 2025. The company is scheduled to deliver more than 80 MW of solar cells to customers by the end of April.
Following the initial deliveries, TOYO plans to ramp up operations significantly. By May and June 2025, the new Ethiopian plant is expected to be fully operational, with a monthly production capacity of 150 to 200 MW. The company recently announced that it is expanding its nameplate capacity at this location to 4GW based on robust external customer demand and the internal needs of its new module facility in Houston Texas. This expansion aligns with TOYO’s broader strategy to strengthen its global solar manufacturing footprint and meet increasing demand for renewable energy solutions.
TOYO’s entry into Ethiopia marks a strategic move to diversify manufacturing locations and leverage regional advantages, supporting sustainable energy growth globally.
“We are very positive about the strong demand we are seeing in the market and are working diligently to execute the additional 2GW expansion in Ethiopia,” said Junsei Ryu, Chairman and CEO of TOYO Co., Ltd. “2025 is shaping up to be a year of massive growth for TOYO fueled by solar power’s ability to rapidly add low-cost power to the grid and our commitment to sustainable energy solutions on a global scale.”
About TOYO Co., Ltd.
TOYO is a solar solutions company that is committed to becoming a full-service solar solutions provider in the global market, integrating the upstream production of wafers and silicon, midstream production of solar cells, downstream production of photovoltaic modules, and potentially other stages of the solar power supply chain. TOYO is well-positioned to produce high-quality solar cells at a competitive scale and cost.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include but are not limited to, statements regarding the expected growth of TOYO, the expected order delivery of TOYO products, TOYO’s construction plan for new facilities and anticipated commencement of production. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of TOYO’s management and are not predictions of actual performance.
These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by these forward-looking statements. Although TOYO believes that it has a reasonable basis for each forward-looking statement contained in this press release, TOYO caution you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. In addition, there are risks and uncertainties described in the documents filed by TOYO from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
TOYO cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to several risks and uncertainties, including, among others, the outcome of any potential litigation, government or regulatory proceedings, the sales performance of TOYO, and other risks and uncertainties, including but not limited to those included under the heading “Risk Factors” of the filings of TOYO with the SEC. There may be additional risks that TOYO does not presently know or that TOYO currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. The forward-looking statements in this press release represent the views of TOYO as of the date of this press release. Subsequent events and developments may cause those views to change. However, while TOYO may update these forward-looking statements in the future, there is no current intention to do so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of TOYO as of any date subsequent to the date of this press release. Except as may be required by law, TOYO does not undertake any duty to update these forward-looking statements.
NEW YORK, April 22, 2025 /PRNewswire/ — ENGWE, a leading brand in the electric bike field, has announced a strategic adjustment to its omnichannel pricing structure, effective May 2025. This change will apply across the entire product line in response to evolving international trade policies.
Tariff Challenges Prompt Strategic Rebalancing
With key components such as lithium-ion batteries, brushless hub motors, controllers, and suspension systems seeing steep cost increases due to tariffs, some rising as much as 25%, ENGWE recognizes the need to adapt. “We’ve worked hard to offset these pressures internally, but quality must never be compromised,” said Baron, ENGWE Product Manager. “This pricing update is a rational decision made after thorough analysis and planning.”
ENGWE is dedicated to ongoing progress to ensure a more stable future
Improving the Supply Chain: We’re making our supply chain more efficient and reducing costs, from sourcing and production to storage and delivery, while boosting flexibility to handle tariff changes.
Enhanced Product Innovation: We continue to invest in R&D and integrate the latest technologies to ensure every ENGWE e-bike delivers outstanding quality, durability, and performance.
Strengthening Global Support: We are expanding our after-sales service network across major international markets to offer faster, more localized, and reliable customer support.
What This Means for Customers
Product Quality: ENGWE e-bikes will continue to offer strong performance, safety, and durability.
Lasting Value: This adjustment supports ongoing innovation and service, ensuring your investment in ENGWE is protected for the long run.
Transparent Shopping Experience: By removing time-limited discounts and guesswork, we focus on providing fair pricing, lasting value, and superior service to every rider, every day.
Enjoy Current Prices During the 11th Anniversary Celebration
To give customers time to enjoy ongoing offers, ENGWE’s pricing changes will begin after the 11th anniversary celebration (April 1–30), which includes a chance to win one of four e-bikes, a €119 cycling gift box with select orders, and discounts of up to €800 on selected models.
In today’s rapidly changing trade and economic landscape, staying proactive and transparent is more important than ever. ENGWE’s price adjustments will take effect in May 2025. We encourage our valued customers to stay informed through our official channels. Thank you for your continued trust and support—together, we will navigate these challenges and drive the future of sustainable mobility.
WUHAN, CHINA – Media OutReach Newswire – 22 April 2025 – During April’s Pear Blossom Festival, Tudianzi village, nestled deep in the mountains of central China’s Hubei Province, has welcomed over 50,000 visitors in just two days. In Tudianzi Village, tourists marveled at innovations like solar-storage integrated streetlights illuminating country paths, high-power EV charging stations eliminating range anxiety, and traditional Tujia cuisine cooked in all-electric kitchens — a vivid showcase of sustainable rural revitalization.
This drone photo shows photovoltaic power station in Tudianzi Village, Badong County, central China’s Hubei Province, April 10, 2025. (Photo by Lei Yong/Xinhua)
From Tudianzi Village, perched 1,200 meters above sea level, the mist-shrouded Wu Gorge stretches into the distance, while terraced pear blossoms blanket the slopes. A light breeze carries the delicate floral fragrance, marking the most picturesque season for this Tujia ethnic mountain village.
“The table actually charges my phone wirelessly!” exclaimed tourist Ms. Tan, surprised when her phone began charging on a solar-powered bench in the food corridor.
Located in Badong County, Enshi Tujia and Miao Autonomous Prefecture, Tudianzi Village earned its name during the Ming Dynasty as a rest stop for merchants on the ancient Tea Horse Road. Long secluded in the mountains, the village has now gained fame as a model for rural energy revolution, achieving 24/7 zero-carbon operations and 100% green electricity supply.
Solar panels are ubiquitous here — on rooftops, pavilions, plaza corridors, chicken coops, and pigsties. “The village’s solar capacity reaches 1,800 kW. At full capacity for one hour, it can generate 1,800 kWh, enough to power the entire village for a day,” said Chen Wentao, person in charge of the State Grid Enshi’s development department.
Reliable electricity was once a distant dream for villagers. Aging power infrastructure — characterized by extensive grid coverage, outdated single-radial network designs, and seasonal load fluctuations — left communities vulnerable to frequent and prolonged outages, particularly during extreme weather.
A staff of State Grid Badong Power Supply Company is checking the breeze power generation equipment in Tudianzi Village. (Photo by Lei Yong/Xinhua)
“Whenever thunderstorms struck, power lines would fail, plunging the entire village into darkness,” recalled 75-year-old Hu De’an. Like many residents, Hu once relied entirely on firewood for light and heat. “Our homes were filled with smoke, but seeing firewood piled under the eaves was the only way we felt secure,” he said.
In September 2020, China unveiled its ambitious “dual carbon” goals to the world: achieving peak carbon emissions by 2030 and carbon neutrality by 2060.
Studies showed that traditional biomass fuels like firewood, burned through direct combustion, operate at a mere 10-15% efficiency while generating heavy carbon emissions. This inefficiency has thrust rural China into a critical dilemma — how to build resilient, clean energy networks that meet growing demand without compromising sustainability.
A breakthrough came in March 2023 when China’s National Energy Administration and three other ministries launched a landmark initiative. The plan prioritizes pilot projects to accelerate rural energy transitions, coupling clean power adoption with broad rural revitalization objectives. By August 2023, State Grid Hubei Electric Power had spearheaded a flagship demonstration project in Tudianzi Village, targeting three pillars: stable clean energy supply, efficient resource utilization, and green industrial development.
During a recent visit to Tudianzi’s black pig breeding base — an operation producing over 4,000 hogs annually — reporters observed a model of integration. Solar panels crowned the spotless pigsty roofs, while odor-free pathways defied backward farm.
The transformation stems from a 30-kilowatt biogas plant constructed adjacent to the facility. Engineered by local power authorities, the system collects manure from the breeding base and kitchen waste from nearby households, channeling them into a closed-loop cycle of “biomass resources – biogas – electricity – fertilizer”.
“Biogas is converted into electricity, while its byproducts — digestate and residues — are processed into fertilizers for farmland, achieving circular biomass utilization and clean energy supply,” said Su Lei, senior engineer of State Grid Hubei Electric Power Research Institute. Notably, the installation of an 80-cubic-meter gas storage tank ensures nighttime green power supply and enables off-grid operations when integrated with flexible energy storage systems.
For local farmer Feng Cailong, the project has brought tangible economic gains. “Previously, disposing pig waste cost over 40,000 yuan annually. Now, delivering it directly to the biogas plant not only cuts disposal expenses but also saves more than 60,000 yuan yearly in electricity, disinfection, and fertilizer costs for forage cultivation,” he informed.
These developments epitomize Tudianzi’s rural energy transformation. After nearly two years of construction, the village has established a low-carbon energy system dominated by wind and solar power, featuring agile microgrid-distribution network interactions and coordinated “source-grid-load-storage” operations. A multidimensional industrial ecosystem integrating renewable energy, livestock farming, and eco-tourism is taking shape.
In 2024, the village’s electricity consumption surged to 537,000 kWh, a 188% increase from 2022. Since launching its energy revolution, Tudianzi’s annual renewable energy output reaches 1.44 million kWh, equivalent to saving 472 tons of standard coal while reducing CO₂ emissions by 1,436 tons and SO₂ by 43 tons annually.
“With the village’s total installed renewable energy capacity now reaching 1,871 kilowatts, we not only achieve full green power supply for the entire village but also export substantial surplus electricity to external grids,” explained Yang Lin, official of the Development and Reform Commission of Enshi Tujia and Miao Autonomous Prefecture.
Hashtag: #EVcharging
The issuer is solely responsible for the content of this announcement.
HO CHI MINH CITY, April 22, 2025 /PRNewswire/ — Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, have entered into a strategic collaboration. The collaboration was formalized with the signing of a Memorandum of Understanding (MoU) during Element Biosciences’ visit to Gene Solutions’ laboratory.
Mr. Edwin Hauw – Element Biosciences Senior Vice President (third from left) and Dr. Nguyen Huu Nguyen – Deputy CEO (third from right) hand over signed MoU
This collaboration aims to create significant synergies by combining Element Biosciences’ groundbreaking sequencing platforms with Gene Solutions’ innovative technologies in genetic solutions. Element Biosciences has rapidly emerged as a leading innovator in the next generation sequencing (NGS) field, delivering novel solutions that provide exceptional performance and flexibility for researchers. Gene Solutions, with its comprehensive portfolio of genetic tests, leveraging NGS and artificial intelligence, has reached over 4,500 hospitals and clinics in eight Asian countries and is actively expanding its global footprint.
Element Bioscience’s Aviti platform at Gene Solutions’ laboratory
Equity in Reproductive Health: Accessibility of Non-invasive Prenatal Testing (NIPT)
NIPT is one of the most well-known clinical applications of NGS technology worldwide. The test screens for genomic abnormalities in cell-free DNA fragments released from the placenta into the mother’s blood[1] and is recommended for all pregnant women from 9-10 weeks of gestation. Over the past eight years, Gene Solutions has developed a strong portfolio of NIPT (trademarked as triSureTM) and a comprehensive ecosystem for reproductive health from pre-birth to newborn and postnatal diagnosis. The company uniquely integrates recessive diseases and dominant single-gene disorders screening in a single workflow with NIPT, leveraging its AI platform and optimized lab protocols. Currently, Gene Solutions is researching the incorporation of pregnancy complications prediction into the NIPT test.
The NIPT market was valued at USD 5.20 billion in 2022 and is projected to grow to USD 19.09 billion by 2030[2]. Gene Solutions seeks to leverage Element’s accessible and affordable research solutions to support its aim to bring safe, accurate, and non-invasive screening tools to all pregnant women.
Precision Oncology: Advancing Cancer Care with Genomic Insights and Cutting-Edge Technology
Early detection is paramount in the fight against cancer. Gene Solutions has commercialized its AI-powered, clinically validated SPOT-MAS test, which has demonstrated strong efficacy in identifying cancers at early stages and those lacking established screening methods[3,4,5]. For cancer patients, the company has developed tailored solutions for selecting targeted therapies and immunotherapies, uniquely combining genomic and transcriptomic tumor profiling with personalized cancer monitoring (K-TRACK, K-4CARE) [6]. Research to support these advancements are made possible by the readiness of NGS platforms and AI algorithms. The collaboration between the two companies aims to further accelerate the research supporting integration of Gene Solution’s advanced cancer care tools into clinical practice globally.
Research into these advancements is made possible through AVITI24™, Element Biosciences’ first-of-its-kind multiomics platform. In addition to providing highly accurate NGS readouts, AVITI24 delivers simultaneous in situ transcriptomic, proteomic, and morphological profiling at single-cell resolution through its powerful Teton™ kits and assays. Powered by Element’s proprietary avidite base chemistry (ABC) sequencing, AVITI24 with Teton provides a direct window into complex biological mechanisms and pathways — paving the way for breakthrough discoveries. AVITI24 will deliver the scalable, unified multi-dimensional data that has long eluded researchers, and ultimately will accelerate the pace of scientific research. Gene Solutions will leverage this cutting-edge platform in its research pipelines, including the Clinical Multi-omics Project, 3D Patient-derived Organoids, and Neoantigen Cancer Vaccine pipeline. These initiatives represent the company’s visionary approach to incorporating Multi-modal AI and Multi-omics insights to unlock next frontiers in therapeutic development.
NGS Testing and Precision Medicine Accessibility
Dr. Nguyen Huu Nguyen, Deputy CEO of Gene Solutions, expressed: “Our foundation is in the research and development of genetic solutions. By combining Element Biosciences’ powerful platform with Gene Solutions’ expertise and market reach, we are confident that we can significantly enhance the accessibility and application of genomic advances.”
Edwin Hauw, Senior Vice President of Marketing & Product Management at Element Biosciences, added: “Our collaboration with Gene Solutions will combine the best of both our worlds: Element’s revolutionary AVITI24 multiomics and AVITI sequencing platforms, and Gene Solutions expertise in bringing transformative genetic solutions to the APAC region. Together, we will elevate the research supporting the real-world impact these genetic testing solutions have downstream on patient outcomes.”
The MoU sets a framework for discussions on strategic partnerships, marketing efforts, customer-centric and technical support, and research and development opportunities. This collaboration promises to leverage the expertise of both parties to enhance genomics research, clinical research applications, and market accessibility for both companies’ global strategies.
About Gene Solutions
Gene Solutions, a multinational biotech company, offers a comprehensive genetic testing portfolio utilizing Next-Generation Sequencing (NGS) and Artificial Intelligence algorithms. The testing services include cell-free DNA non-invasive prenatal testing (NIPT), circulating tumor DNA (ctDNA) cancer screening, genomic profiling, and treatment monitoring. Established in 2017, Gene Solutions operates a network of seven NGS laboratories, including two central CAP-accredited laboratories in Singapore and Vietnam. With over two million tests provided to patients, we remain committed to delivering accessible genetic testing services to more than 4,500 hospitals and clinics across Singapore, Vietnam, Thailand, Indonesia, Malaysia, the Philippines, Hong Kong, and Taiwan. To learn more about Gene Solutions, please visit genesolutions.com. Media Contact: pr@genesolutions.com
About Element Biosciences, Inc.
Element Biosciences is a life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific research. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook. Media Contact: media@elembio.com
References:
[1] ACOG current guidance, accessed 04 April 2025. [2] Fortune Business Insights. [3] Nguyen, L. H. D., et al. (2025). Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Medicine, 23(1). [4] Carbonell, Chantelle, et al. Cancer Control 31 (2024). [5] Thien Nguyen, Chi Van, et al. “Evaluation of a multimodal ctDNA-based assay for detection of aggressive cancers lacking standard screening tests.” Future Oncology (2024): 1-11. [6] Van-Anh Nguyen Hoang, et al. Real-World Utilization and Performance of Circulating Tumor DNA Monitoring to Predict Recurrence in Solid Tumors. JCO Oncology Advances 2, e2400084 (2025).